By Joseph Walker Health officials around the country are preparing to resume offering Johnson & Johnson s Covid-19 vaccine as soon as this weekend after getting a green light from federal regulators on Friday. The U.S. Food and Drug Administration and U.S. Centers for Disease Control and Prevention lifted their recommendation to pause the shots after investigating reports of rare but potentially dangerous blood clotting in certain recipients. On Friday, FDA and CDC officials said inoculations could continue because their benefits outweigh their risks. Vaccinations can begin as soon as Saturday morning, said FDA s vaccines chief Peter Marks on a conference call with reporters Friday. The FDA issued updated informational guides that inform vaccine recipients and doctors of the risk of a blood-clotting side effect that has primarily affected adult women under 50. The overall risk is about 1.9 cases per million people, though the risk is about 3.5 times higher for wo
Northwell
Arizona
United-states
Minnesota
Yale-new-haven-hospital
Connecticut
Washington
Joseph-walker
Peter-marks
Thomas-balcezak
Umair-shah
Onisis-stefas
Pfizer s COVID-19 vaccine found to be highly effective for adolescents
Posted Yesterday at 11:39pm
WedWednesday 31
Caleb Chung was one of the participants in the study in the US.
(
Share
Print text only
Cancel
Pfizer and BioNTech s COVID-19 vaccine is safe, effective and produces robust antibody responses in 12- to 15-year olds, according to a trial run by the companies.
Key points:
No cases were detected in the trial group who got the vaccine, compared with 18 in the placebo group
The trial participants experienced the same side-effects that had been noted in adults
Pfizer hopes to begin vaccinating US teenagers before the new school year
Australia
Northwell
Western-australia
United-kingdom
Britain
Albert-bourla
Onisis-stefas
Pfizer
Astrazeneca
Northwell-health
Moderna-inc
Young